AQP1 and prostate adenocarcinoma: Immunohistochemical expression of AQP1 has been demonstrated as a prognostic biomarker in several solid tumours, including mesothelioma, breast cancer, colorectal cancer, brain tumours, prostate adenocarcinoma, lung adenocarcinoma, and ovarian cancer [38,39,40,41].